Brief: Tango Therapeutics Q2 Basic EPS USD -0.37
11/08/2026 12:01
BRIEF-Tango Therapeutics Q2 Basic EPS USD -0.37 Aug 11 (Reuters) - Tango Therapeutics Q2 operating expenses USD 59.785 million.
- Q2 operating income USD -59.785 million
- Q2 net income USD -55.341 million
- Q2 EPS USD -0.37
Recent news on Tango Therapeutics
See all newsBrief: Tango Therapeutics, Inc. Approved A Strategic Reprioritization Of The Company’S Research And Development Activities
Brief: Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Tango Therapeutics - Files Prospectus To Sell Up To $400 Million In Common Stock
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,